Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to GABAergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium

Journal of Neuroscience

Volumn 21, Issue 3, 2001, Pages 798-811

  Stumm, Ralf K ^a   Culmsee, Carsten ^a   Schäfer, Martin K H ^a   Krieglstein, Josef ^a   Weihe, Eberhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Astrocyte; Blood brain barrier; Inflammation; Neuroimmune; Neuropeptide; Stroke

Indexed keywords

GLUTAMATE RECEPTOR; NEUROKININ B; NEUROPEPTIDE; PREPROTACHYKININ; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CAUDATE NUCLEUS; CELL SPECIFICITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GABAERGIC SYSTEM; GENE EXPRESSION; GLIOSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTERNEURON; MACROGLIA; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; PYRAMIDAL NERVE CELL; RAT;

EID: 0035112614     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-03-00798.2001     Document Type: Article

References (76)

1. Demonstration of tissue-specific gene expression by in situ hybridization
2. Upregulation of substance P receptors in angiogenesis associated with chronic airway inflammation in rats
3. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats
4. Distinct modifications by neurokinin1 (SR140333) and neurokinin2 (SR48968) tachykinin receptor antagonists of the N-methyl-D-aspartate-evoked release of acetylcholine in striosomes and matrix of the rat striatum
5. A cDNA encoding the precursor of the rat neuropeptide, neurokinin B
6. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation
7. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma
8. Enhanced secretion of substance P by cytokine-stimulated rat brain endothelium cultures
9. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke
10. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage
11. The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat
12. Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia
13. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis
14. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat
15. Pathobiology of ischaemic stroke: An integrated view
16. Neuroimmune appendicitis
17. The glycine site of the NMDA receptor contributes to neurokinin1 receptor agonist facilitation of NMDA receptor agonist-evoked activity in rat dorsal horn neurons
18. Organization, structure, and expression of the gene encoding the rat substance P receptor
19. Neurogenic vasodilatation and plasma leakage in the skin
20. Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study
21. Glutamate-synthesizing enzymes in GABAergic neurons of the neocortex: A double immunofluorescence study in the rat
22. Morphological and chemical characteristics of substance P receptor-immunoreactive neurons in the rat neocortex
23. Characterization of neocortical non-pyramidal neurons expressing preprotachykinins A and B: A double immunofluorescence study in the rat
24. A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei
25. The changing landscape of ischaemic brain injury mechanisms
26. Substance P enhances NMDA channel function in hippocampal dentate gyrus granule cells
27. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene
28. Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals
29. Localization of the tachykinin neurokinin B precursor peptide in rat brain by immunocytochemistry and in situ hybridization
30. Chronic trigeminal ganglionectomy or topical capsaicin application to pial vessels attenuates postocclusive cortical hyperemia but does not influence postischemic hypoperfusion
31. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system
32. The effects of tachykinins on inflammatory and immune cells
33. Substance P receptor binding sites are expressed by glia in vivo after neuronal injury
34. Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis
35. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: An in vivo microdialysis approach in guinea pig
36. Limbic seizures cause pronounced changes in the expression of neurokinin B in the hippocampus of the rat
37. Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating GABAergic inhibition
38. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter
39. Neurokinin-3 receptor distribution in rat and human brain: An immunohistochemical study
40. Distribution of messenger RNAs encoding the enzymes glutaminase, aspartate aminotransferase and glutamic acid decarboxylase in rat brain
41. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration
42. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat
43. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P
44. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization
45. Electrophysiological transcortical diaschisis after middle cerebral artery occlusion (MCAO) in rats
46. Kainic acid induced seizures cause a marked increase in the expression of neurokinin-3 receptor mRNA in the rat cerebellum
47. Upregulation of COX-2 and CGRP expression in resident cells of the Borna disease virus-infected brain is dependent upon inflammation
48. Status epilepticus in stroke: Report on a hospital-based stroke cohort
49. Involvement of leukotrienes, TNF-alpha, and the LFA-1/ICAM-1 interaction in substance P-induced granulocyte infiltration
50. Molecular characterization of rat substance K receptor and its mRNAs
51. In situ hybridization techniques to map processing enzymes
52. Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones
53. Complement C1q is dramatically upregulated in brain microglia in response to transient global cerebral ischemia
54. Follicular dendritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis
55. Isolation, characterization, and in vitro expression of a cDNA that encodes the kidney isoenzyme of the mitochondrial glutaminase
56. The non-peptide neurokininl receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats
57. Cloning and expression of a rat neuromedin K receptor cDNA
58. Immunocytochemical localization of rat substance P receptor in the striatum
59. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system
60. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: Quantitative radioimmunocytochemical and in situ hybridization evidence
61. Salient features of synaptic organisation in the cerebral cortex
62. A change of P-selectin immunoreactivity in rat brain after transient and permanent middle cerebral artery occlusion
63. Focal cerebral ischaemia in the rat. 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion
64. Preprotachykinin-A and substance P receptor (NK1) gene expression in rat astrocytes in vitro
65. Tachykinin induced regulation of excitatory amino acid responses in the rat spinal cord in vitro
66. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum
67. Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex
68. Distribution of cells containing mR-NAs encoding substance P and neurokinin B in the rat central nervous system
69. The tachykinin neuroimmune connection in inflammatory pain
70. Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus
71. Expression of neuropeptides, neuropeptide receptors and neuropeptide processing enzymes in spinal neurons and peripheral non-neuronal cells and plasticity in models of inflammatory pain
72. Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B
73. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra
74. Characterization of a cDNA coding for rat glutamic acid decarboxylase
75. Neurokinin-1 receptor antagonist SR140333: A novel type of drug to treat cerebral ischemia
76. A tachykinin NK1 receptor antagonist, CP-122, 721-1, attenuates kainic acid-induced seizure activity